Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Emre Özgenç"'
Publikováno v:
ACS Omega, Vol 5, Iss 10, Pp 5297-5305 (2020)
Externí odkaz:
https://doaj.org/article/d4fade7dbcbd46b8a5c411b2b13479d1
Autor:
Panoraia I. Siafaka, Mehmet Evren Okur, Pelin Dilsiz Erim, Emre Şefik Çağlar, Emre Özgenç, Evren Gündoğdu, Rabia Edibe Parlar Köprülü, Ioannis D. Karantas, Neslihan Üstündağ Okur
Publikováno v:
Pharmaceutics, Vol 14, Iss 11, p 2425 (2022)
It has been estimated that every year, millions of people are affected by neurodegenerative disorders, which complicate their lives and their caregivers’ lives. To date, there has not been an approved pharmacological approach to provide the complet
Externí odkaz:
https://doaj.org/article/446a9a4451294957bc277b99aa7bc3a3
Publikováno v:
Turkish Journal of Pharmaceutical Sciences. 20:91-99
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c4bcb9a2848b192ad2d175b9680fe6a
https://doi.org/10.4274/tjps.galenos.2022.01346
https://doi.org/10.4274/tjps.galenos.2022.01346
Publikováno v:
Volume: 47, Issue: 3 369-380
Fabad Eczacılık Bilimler Dergisi
Fabad Journal of Pharmaceutical Sciences
Fabad Eczacılık Bilimler Dergisi
Fabad Journal of Pharmaceutical Sciences
Enfeksiyon hastalıkları hala dünyada temel sağlık problemlerinden birini oluşturmaktadır. Enfeksiyonun erken aşamalarda teşhisi ve kanser veya inflamasyon gibi diğer patolojilerden ayrımı, enfeksiyonu akut aşamalarda tedavi etmede kritik
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a833f58035f59d9ec0cfa90254236da5
https://dergipark.org.tr/tr/pub/fabadeczacilik/issue/73089/1099287
https://dergipark.org.tr/tr/pub/fabadeczacilik/issue/73089/1099287
Autor:
Neslihan Üstündağ Okur, Panoraia I. Siafaka, Evren Atlıhan Gündoğdu, Emre Sefik Cağlar, Emre Özgenç, Marta Gonzalez-Alvarez, Isabel Gonzalez-Alvarez
Publikováno v:
Current drug delivery.
Background: Currently, there is ongoing research in the pharmaceutical technology field to develop innovative drug delivery systems with improved therapeutic efficacy. Objectives: Although there is a high need for new drug molecules, most scientists
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bedbc3957d7d9ddffa17df91662af075
https://pubmed.ncbi.nlm.nih.gov/36082850
https://pubmed.ncbi.nlm.nih.gov/36082850
Autor:
Ekici, Emre Özgenç
Finding optimum schedules for High Mix Low Volume, multistage Hybrid Flow Shop (HFS) areas, is regular and hard problem. For these kinds of production areas, there are many specific Mixed Integer Programs in literature. In this thesis, another Mixed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4268::3fd410e4f1437ec9fbfdf4b3c4b4e2dd
http://hdl.handle.net/11655/2443
http://hdl.handle.net/11655/2443
Autor:
Evren Atlihan Gundogdu, Emine Selin Demir, Meliha Ekinci, Emre Ozgenc, Derya Ilem Ozdemir, Zeynep Senyigit, Makbule Asikoglu
Publikováno v:
Drug Delivery, Vol 27, Iss 1, Pp 1695-1703 (2020)
The aim of current study is to develop new nanostructured lipid carrier systems (NLCSs) containing imatinib mesylate (IMT) and evaluate their targeting efficiency on NIH-3T3 as fibroblast cells and CRL-1739 as gastric adenocarcinoma cells with radiol
Externí odkaz:
https://doaj.org/article/6e4c8f012dc5489b8d1cb87b2cfd4055
Autor:
Evren Gundogdu, Emine-Selin Demir, Meliha Ekinci, Emre Ozgenc, Derya Ilem-Ozdemir, Zeynep Senyigit, Isabel Gonzalez-Alvarez, Marival Bermejo
Publikováno v:
Nanomaterials, Vol 12, Iss 2, p 250 (2022)
Imatinib (IMT) is a tyrosine kinase enzyme inhibitor and extensively used for the treatment of gastrointestinal stromal tumors (GISTs). A nanostructured lipid carrier system (NLCS) containing IMT was developed by using emulsification–sonication met
Externí odkaz:
https://doaj.org/article/eb81636e80164718be67c99506151091